Retevmo 120 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJK09
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,358
Award facts
- Contract value 100% obligated
- $15,358.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15.4K to AmerisourceBergen Drug Corp for the supply of RETEVMO (selpercatinib) 120 mg tablets in a quantity of 60 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued on August 13, 2025, and scheduled for completion by September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. RETEVMO is a targeted cancer therapy, consistent with AmerisourceBergen's portfolio of specialized pharmaceutical products distributed through the DLA's global pharmaceutical support vehicle serving the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJK09?
SPE2DB25FJK09 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FJK09 worth?
The government has obligated $15,358 on SPE2DB25FJK09.
Is contract SPE2DB25FJK09 an order under another contract?
Yes. SPE2DB25FJK09 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJK09 competed?
The extent of competition for SPE2DB25FJK09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award